Vestibular Neuronitis Clinical Trial
Official title:
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs): A Comparative Study of Normal Ears Versus Those With Vestibular Deficits
The pathophysiology of vertigo is complex and usually requires specialist involvement.
During the diagnostic process, patients commonly undergo tests which assess the integrity of
the gaze and posture stabilisation mechanisms involving the inner ear (vestibular system),
the visual systems and the subconscious neural pathways that interconnect them. Whilst these
tests are useful they fail to provide information concerning the neural connections to the
cortex and therefore neglect the perceptual aspects of disequilibrium.
At present the possibility of routine examination of these higher projections remains
elusive as no practical alternatives to the expensive functional magnetic resonance imaging
systems exist. However, recently a novel method of recording cortical vestibular evoked
potentials (CVEPs) has been described.
CVEPs utilise an existing method used to interrogate cortical projections from the auditory
system in which sound waves stimulate the inner ear and the resulting electrical responses
from the brain are recorded. The recent breakthrough is in the realisation that these
responses also contain information from the balance organs and therefore are a direct
measure of cortical processing of the vestibular inputs.
Current evidence shows that CVEPs are present in the normal population and absent in
patients with no vestibular function. The primary aim for this study is to extend the
patient cohort to include those who have a vestibular injury but retain residual function.
Patients going through standard testing will have also have CVEPs on both ears providing
seminal information into the effect of injury to the peripheral vestibular system on the
cortical pathways. Furthermore, by following the cohort through their complete management
pathway it will be possible to ascertain if the CVEP can be used to predict rehabilitation
outcome success.
Ears with a vestibular deficit:
Patients referred to the tertiary ear nose and throat clinics as well otoneurological
clinics at the Royal Hallamshire will be eligible for enrolment. The investigators aim to
record data from 36 ears with vestibular dysfunction.
A) Patients will receive a consultation with an ENT Consultant or Registrar as per standard
practice.
B) If the patient is deemed by the doctor to have an otoneurological cause for their
symptoms then further audiovestibular testing and imaging will be arranged as per standard
practice. The patients will then be made aware of this study and if interested will be given
the opportunity to discuss it further with the chief investigator (CI) or the principal
investigator (PI).
C) If agreeable the patients will be given information packs by the PI/CI and taken through
the study.
D) The patients will leave the consultation with the information pack and be asked to
consider participation in the study. They will have no obligation to take part and they can
contact the any member of the research team to ask for further information or to have any
questions answered.
E) Upon their return for audiovestibular testing the patients will inform the CI/PI if they
wish to participate in the study and if so will have an additional test at the end of test
sequence. This will add approximately 30 minutes to their appointment time.
F) Patients who are suitable for rehabilitation (as per standard care pathway) will go ahead
and have the course of treatment at subsequent visit(s). The outcomes following the
treatment will be logged and correlated with the CVEP to check for any correlation that may
or may not be present.
Otologically normal ears:
Normative data will be collected from 36 normal ears from subjects that have no history of
audiovestibular symptoms and are not being investigated for any balance disorders. Healthy
controls will be recruited via poster advertisements and potential participants asked to
contact the research team if they are considering taking part.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00271791 -
Prednisone Treatment for Vestibular Neuronitis
|
Phase 2 | |
Completed |
NCT01943955 -
Home-based Computer Gaming in Vestibular Rehabilitation
|
N/A | |
Not yet recruiting |
NCT05424302 -
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
|
N/A | |
Terminated |
NCT02912182 -
Acute Unilateral Vestibulopathy and Corticosteroid Treatment
|
Phase 4 | |
Completed |
NCT00411216 -
Recovery of Visual Acuity in People With Vestibular Deficits
|
N/A | |
Completed |
NCT00032383 -
Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System
|
Phase 1/Phase 2 |